Get expert advice and insights on any topic with IDNLearn.com. Get timely and accurate answers to your questions from our dedicated community of experts who are here to help you.
Answer: In January 2021, the EMA received an application for conditional marketing authorization (CMA) for the COVID‑19 vaccine known as COVID‑19 Vaccine AstraZeneca, developed by AstraZeneca and Oxford University.